APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Discovery Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Drug Discovery Platform Market Outlook and Growth Opportunities 2026

4 July 2026209 pages

Choose your research edition.

Industry ResearchAI Drug Discovery Platform Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Discovery Platform Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal AI Drug Discovery Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Discovery Platform Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Discovery Platform Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global AI Drug Discovery Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Drug Discovery Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Drug Discovery Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Drug Discovery Platform market include Exscientia, Iktos, Delta4, Healx, Innoplexus, BenevolentAI, Evaxion, Genome Biologics and Novadiscovery, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Drug Discovery Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Drug Discovery Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Drug Discovery Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Drug Discovery Platform market.

AI Drug Discovery Platform Segment by Company

Exscientia

Iktos

Delta4

Healx

Innoplexus

BenevolentAI

Evaxion

Genome Biologics

Novadiscovery

Nuritas

CytoReason

Turbine Simulated Cell Technologies

Atomwise

Recursion

Insilico Medicine

Relay Therapeutics

Pfizer

Janssen

AstraZeneca

Beijing Iipharma

AI Drug Discovery Platform Segment by Type

Drug Discovery

Drug Design

AI Drug Discovery Platform Segment by Application

Pharmaceutical Company

Biotech Company

Contract Research Organization

Others

AI Drug Discovery Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Drug Discovery Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Drug Discovery Platform key companies, revenue, market share, and recent developments.

3. To split the AI Drug Discovery Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Drug Discovery Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Drug Discovery Platform significant trends, drivers, influence factors in global and regions.

6. To analyze AI Drug Discovery Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Drug Discovery Platform industry.

Chapter 3: Detailed analysis of AI Drug Discovery Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Drug Discovery Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Drug Discovery Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Drug Discovery Platform Industry Trends Table 2. AI Drug Discovery Platform Industry Drivers Table 3. AI Drug Discovery Platform Industry Opportunities and Challenges Table 4. AI Drug Discovery Platform Industry Restraints Table 5. Global AI Drug Discovery Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Drug Discovery Platform Revenue Share by Company (2021-2026) Table 7. Global AI Drug Discovery Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Drug Discovery Platform Key Company Manufacturing Base & Headquarters Table 9. Global AI Drug Discovery Platform Company, Product Type & Application Table 10. Global AI Drug Discovery Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Drug Discovery Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Drug Discovery Table 15. Significant Companies of Drug Design Table 16. Global AI Drug Discovery Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI Drug Discovery Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI Drug Discovery Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI Drug Discovery Platform Sales Value Share by Type (2021-2026) Table 20. Global AI Drug Discovery Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical Company Table 22. Significant Companies of Biotech Company Table 23. Significant Companies of Contract Research Organization Table 24. Significant Companies of Others Table 25. Global AI Drug Discovery Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI Drug Discovery Platform Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global AI Drug Discovery Platform Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global AI Drug Discovery Platform Sales Value Share by Application (2021-2026) Table 29. Global AI Drug Discovery Platform Sales Value Share by Application (2027-2032) Table 30. Global AI Drug Discovery Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Drug Discovery Platform Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global AI Drug Discovery Platform Sales Value Share by Region (2021-2026) Table 33. Global AI Drug Discovery Platform Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global AI Drug Discovery Platform Sales Value Share by Region (2027-2032) Table 35. Global AI Drug Discovery Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI Drug Discovery Platform Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global AI Drug Discovery Platform Sales Value Market Share by Country (2021-2026) Table 38. Global AI Drug Discovery Platform Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global AI Drug Discovery Platform Sales Value Market Share by Country (2027-2032) Table 40. Exscientia Company Information Table 41. Exscientia Business Overview Table 42. Exscientia AI Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Exscientia AI Drug Discovery Platform Product Portfolio Table 44. Exscientia Recent Development Table 45. Iktos Company Information Table 46. Iktos Business Overview Table 47. Iktos AI Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Iktos AI Drug Discovery Platform Product Portfolio Table 49. Iktos Recent Development Table 50. Delta4 Company Information Table 51. Delta4 Business Overview Table 52. Delta4 AI Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Delta4 AI Drug Discovery Platform Product Portfolio Table 54. Delta4 Recent Development Table 55. Healx Company Information Table 56. Healx Business Overview Table 57. Healx AI Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Healx AI Drug Discovery Platform Product Portfolio Table 59. Healx Recent Development Table 60. Innoplexus Company Information Table 61. Innoplexus Business Overview Table 62. Innoplexus AI Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Innoplexus AI Drug Discovery Platform Product Portfolio Table 64. Innoplexus Recent Development Table 65. BenevolentAI Company Information Table 66. BenevolentAI Business Overview Table 67. BenevolentAI AI Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. BenevolentAI AI Drug Discovery Platform Product Portfolio Table 69. BenevolentAI Recent Development Table 70. Evaxion Company Information Table 71. Evaxion Business Overview Table 72. Evaxion AI Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Evaxion AI Drug Discovery Platform Product Portfolio Table 74. Evaxion Recent Development Table 75. Genome Biologics Company Information Table 76. Genome Biologics Business Overview Table 77. Genome Biologics AI Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Genome Biologics AI Drug Discovery Platform Product Portfolio Table 79. Genome Biologics Recent Development Table 80. Novadiscovery Company Information Table 81. Novadiscovery Business Overview Table 82. Novadiscovery AI Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Novadiscovery AI Drug Discovery Platform Product Portfolio Table 84. Novadiscovery Recent Development Table 85. Nuritas Company Information Table 86. Nuritas Business Overview Table 87. Nuritas AI Drug Discovery Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Nuritas AI Drug Discovery Platform Product Portfolio Table 89. Nuritas Recent Development Table 90. CytoReason Company Information Table 91. CytoReason Business Overview Table 92. CytoReason AI Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. CytoReason AI Drug Discovery Platform Product Portfolio Table 94. CytoReason Recent Development Table 95. Turbine Simulated Cell Technologies Company Information Table 96. Turbine Simulated Cell Technologies Business Overview Table 97. Turbine Simulated Cell Technologies AI Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Turbine Simulated Cell Technologies AI Drug Discovery Platform Product Portfolio Table 99. Turbine Simulated Cell Technologies Recent Development Table 100. Atomwise Company Information Table 101. Atomwise Business Overview Table 102. Atomwise AI Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Atomwise AI Drug Discovery Platform Product Portfolio Table 104. Atomwise Recent Development Table 105. Recursion Company Information Table 106. Recursion Business Overview Table 107. Recursion AI Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Recursion AI Drug Discovery Platform Product Portfolio Table 109. Recursion Recent Development Table 110. Insilico Medicine Company Information Table 111. Insilico Medicine Business Overview Table 112. Insilico Medicine AI Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Insilico Medicine AI Drug Discovery Platform Product Portfolio Table 114. Insilico Medicine Recent Development Table 115. Relay Therapeutics Company Information Table 116. Relay Therapeutics Business Overview Table 117. Relay Therapeutics AI Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Relay Therapeutics AI Drug Discovery Platform Product Portfolio Table 119. Relay Therapeutics Recent Development Table 120. Pfizer Company Information Table 121. Pfizer Business Overview Table 122. Pfizer AI Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Pfizer AI Drug Discovery Platform Product Portfolio Table 124. Pfizer Recent Development Table 125. Janssen Company Information Table 126. Janssen Business Overview Table 127. Janssen AI Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Janssen AI Drug Discovery Platform Product Portfolio Table 129. Janssen Recent Development Table 130. AstraZeneca Company Information Table 131. AstraZeneca Business Overview Table 132. AstraZeneca AI Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. AstraZeneca AI Drug Discovery Platform Product Portfolio Table 134. AstraZeneca Recent Development Table 135. Beijing Iipharma Company Information Table 136. Beijing Iipharma Business Overview Table 137. Beijing Iipharma AI Drug Discovery Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Beijing Iipharma AI Drug Discovery Platform Product Portfolio Table 139. Beijing Iipharma Recent Development Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. AI Drug Discovery Platform Product Image Figure 2. Global AI Drug Discovery Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Discovery Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Drug Discovery Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Drug Discovery Image Figure 8. Drug Design Image Figure 9. Global AI Drug Discovery Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI Drug Discovery Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI Drug Discovery Platform Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical Company Image Figure 13. Biotech Company Image Figure 14. Contract Research Organization Image Figure 15. Others Image Figure 16. Global AI Drug Discovery Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI Drug Discovery Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global AI Drug Discovery Platform Sales Value Share by Application (2021-2032) Figure 19. Global AI Drug Discovery Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global AI Drug Discovery Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America AI Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 22. North America AI Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe AI Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Europe AI Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific AI Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific AI Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America AI Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 28. South America AI Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa AI Drug Discovery Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa AI Drug Discovery Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt AI Drug Discovery Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Drug Discovery
  • Drug Design
Applications
  • Pharmaceutical Company
  • Biotech Company
  • Contract Research Organization
  • Others
Companies covered
  • Exscientia
  • Iktos
  • Delta4
  • Healx
  • Innoplexus
  • BenevolentAI
  • Evaxion
  • Genome Biologics
  • Novadiscovery
  • Nuritas
  • CytoReason
  • Turbine Simulated Cell Technologies
  • Atomwise
  • Recursion
  • Insilico Medicine
  • Relay Therapeutics
  • Pfizer
  • Janssen
  • AstraZeneca
  • Beijing Iipharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Drug Discovery Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Drug Discovery Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Drug Discovery Platform Market Dynamics
  1. 2.1 AI Drug Discovery Platform Industry Trends
  2. 2.2 AI Drug Discovery Platform Industry Drivers
  3. 2.3 AI Drug Discovery Platform Industry Opportunities and Challenges
  4. 2.4 AI Drug Discovery Platform Industry Restraints
3 AI Drug Discovery Platform Market by Company
  1. 3.1 Global AI Drug Discovery Platform Company Revenue Ranking in 2025
  2. 3.2 Global AI Drug Discovery Platform Revenue by Company (2021-2026)
  3. 3.3 Global AI Drug Discovery Platform Company Ranking (2024-2026)
  4. 3.4 Global AI Drug Discovery Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Drug Discovery Platform Company Product Type and Application
  6. 3.6 Global AI Drug Discovery Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Drug Discovery Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Drug Discovery Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Drug Discovery Platform Market by Type
  1. 4.1 AI Drug Discovery Platform Type Introduction
  2. 4.1.1 Drug Discovery
  3. 4.1.2 Drug Design
  4. 4.2 Global AI Drug Discovery Platform Sales Value by Type
  5. 4.2.1 Global AI Drug Discovery Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI Drug Discovery Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI Drug Discovery Platform Sales Value Share by Type (2021-2032)
5 AI Drug Discovery Platform Market by Application
  1. 5.1 AI Drug Discovery Platform Application Introduction
  2. 5.1.1 Pharmaceutical Company
  3. 5.1.2 Biotech Company
  4. 5.1.3 Contract Research Organization
  5. 5.1.4 Others
  6. 5.2 Global AI Drug Discovery Platform Sales Value by Application
  7. 5.2.1 Global AI Drug Discovery Platform Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global AI Drug Discovery Platform Sales Value by Application (2021-2032)
  9. 5.2.3 Global AI Drug Discovery Platform Sales Value Share by Application (2021-2032)
6 AI Drug Discovery Platform Regional Value Analysis
  1. 6.1 Global AI Drug Discovery Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Drug Discovery Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Drug Discovery Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Drug Discovery Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Drug Discovery Platform Sales Value (2021-2032)
  7. 6.3.2 North America AI Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Drug Discovery Platform Sales Value (2021-2032)
  10. 6.4.2 Europe AI Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Drug Discovery Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Drug Discovery Platform Sales Value (2021-2032)
  16. 6.6.2 South America AI Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Drug Discovery Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Drug Discovery Platform Sales Value Share by Country, 2025 VS 2032
7 AI Drug Discovery Platform Country-level Value Analysis
  1. 7.1 Global AI Drug Discovery Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Drug Discovery Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Drug Discovery Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Drug Discovery Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Drug Discovery Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Drug Discovery Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Drug Discovery Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Exscientia
  2. 8.1.1 Exscientia Company Information
  3. 8.1.2 Exscientia Business Overview
  4. 8.1.3 Exscientia AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Exscientia AI Drug Discovery Platform Product Portfolio
  6. 8.1.5 Exscientia Recent Developments
  7. 8.2 Iktos
  8. 8.2.1 Iktos Company Information
  9. 8.2.2 Iktos Business Overview
  10. 8.2.3 Iktos AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Iktos AI Drug Discovery Platform Product Portfolio
  12. 8.2.5 Iktos Recent Developments
  13. 8.3 Delta4
  14. 8.3.1 Delta4 Company Information
  15. 8.3.2 Delta4 Business Overview
  16. 8.3.3 Delta4 AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Delta4 AI Drug Discovery Platform Product Portfolio
  18. 8.3.5 Delta4 Recent Developments
  19. 8.4 Healx
  20. 8.4.1 Healx Company Information
  21. 8.4.2 Healx Business Overview
  22. 8.4.3 Healx AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Healx AI Drug Discovery Platform Product Portfolio
  24. 8.4.5 Healx Recent Developments
  25. 8.5 Innoplexus
  26. 8.5.1 Innoplexus Company Information
  27. 8.5.2 Innoplexus Business Overview
  28. 8.5.3 Innoplexus AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Innoplexus AI Drug Discovery Platform Product Portfolio
  30. 8.5.5 Innoplexus Recent Developments
  31. 8.6 BenevolentAI
  32. 8.6.1 BenevolentAI Company Information
  33. 8.6.2 BenevolentAI Business Overview
  34. 8.6.3 BenevolentAI AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 BenevolentAI AI Drug Discovery Platform Product Portfolio
  36. 8.6.5 BenevolentAI Recent Developments
  37. 8.7 Evaxion
  38. 8.7.1 Evaxion Company Information
  39. 8.7.2 Evaxion Business Overview
  40. 8.7.3 Evaxion AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Evaxion AI Drug Discovery Platform Product Portfolio
  42. 8.7.5 Evaxion Recent Developments
  43. 8.8 Genome Biologics
  44. 8.8.1 Genome Biologics Company Information
  45. 8.8.2 Genome Biologics Business Overview
  46. 8.8.3 Genome Biologics AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genome Biologics AI Drug Discovery Platform Product Portfolio
  48. 8.8.5 Genome Biologics Recent Developments
  49. 8.9 Novadiscovery
  50. 8.9.1 Novadiscovery Company Information
  51. 8.9.2 Novadiscovery Business Overview
  52. 8.9.3 Novadiscovery AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novadiscovery AI Drug Discovery Platform Product Portfolio
  54. 8.9.5 Novadiscovery Recent Developments
  55. 8.10 Nuritas
  56. 8.10.1 Nuritas Company Information
  57. 8.10.2 Nuritas Business Overview
  58. 8.10.3 Nuritas AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nuritas AI Drug Discovery Platform Product Portfolio
  60. 8.10.5 Nuritas Recent Developments
  61. 8.11 CytoReason
  62. 8.11.1 CytoReason Company Information
  63. 8.11.2 CytoReason Business Overview
  64. 8.11.3 CytoReason AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CytoReason AI Drug Discovery Platform Product Portfolio
  66. 8.11.5 CytoReason Recent Developments
  67. 8.12 Turbine Simulated Cell Technologies
  68. 8.12.1 Turbine Simulated Cell Technologies Company Information
  69. 8.12.2 Turbine Simulated Cell Technologies Business Overview
  70. 8.12.3 Turbine Simulated Cell Technologies AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Turbine Simulated Cell Technologies AI Drug Discovery Platform Product Portfolio
  72. 8.12.5 Turbine Simulated Cell Technologies Recent Developments
  73. 8.13 Atomwise
  74. 8.13.1 Atomwise Company Information
  75. 8.13.2 Atomwise Business Overview
  76. 8.13.3 Atomwise AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Atomwise AI Drug Discovery Platform Product Portfolio
  78. 8.13.5 Atomwise Recent Developments
  79. 8.14 Recursion
  80. 8.14.1 Recursion Company Information
  81. 8.14.2 Recursion Business Overview
  82. 8.14.3 Recursion AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Recursion AI Drug Discovery Platform Product Portfolio
  84. 8.14.5 Recursion Recent Developments
  85. 8.15 Insilico Medicine
  86. 8.15.1 Insilico Medicine Company Information
  87. 8.15.2 Insilico Medicine Business Overview
  88. 8.15.3 Insilico Medicine AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Insilico Medicine AI Drug Discovery Platform Product Portfolio
  90. 8.15.5 Insilico Medicine Recent Developments
  91. 8.16 Relay Therapeutics
  92. 8.16.1 Relay Therapeutics Company Information
  93. 8.16.2 Relay Therapeutics Business Overview
  94. 8.16.3 Relay Therapeutics AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Relay Therapeutics AI Drug Discovery Platform Product Portfolio
  96. 8.16.5 Relay Therapeutics Recent Developments
  97. 8.17 Pfizer
  98. 8.17.1 Pfizer Company Information
  99. 8.17.2 Pfizer Business Overview
  100. 8.17.3 Pfizer AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Pfizer AI Drug Discovery Platform Product Portfolio
  102. 8.17.5 Pfizer Recent Developments
  103. 8.18 Janssen
  104. 8.18.1 Janssen Company Information
  105. 8.18.2 Janssen Business Overview
  106. 8.18.3 Janssen AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Janssen AI Drug Discovery Platform Product Portfolio
  108. 8.18.5 Janssen Recent Developments
  109. 8.19 AstraZeneca
  110. 8.19.1 AstraZeneca Company Information
  111. 8.19.2 AstraZeneca Business Overview
  112. 8.19.3 AstraZeneca AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  113. 8.19.4 AstraZeneca AI Drug Discovery Platform Product Portfolio
  114. 8.19.5 AstraZeneca Recent Developments
  115. 8.20 Beijing Iipharma
  116. 8.20.1 Beijing Iipharma Company Information
  117. 8.20.2 Beijing Iipharma Business Overview
  118. 8.20.3 Beijing Iipharma AI Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Beijing Iipharma AI Drug Discovery Platform Product Portfolio
  120. 8.20.5 Beijing Iipharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst